Background To study the prevalence and risk factors of fragility fractures in patients with SLE.Methods 383 patients who fulfilled ≥4 ACR criteria for SLE and had a DEXA scan performed (baseline) were ...

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2- to 10-fold higher risk of ischemic heart ...

Objective The objective of this review is to highlight the role of Neutrophil Extracellular Traps (NETs) in the pathogenesis of Systemic Lupus Erythematosus (SLE), focusing on their development, ...

Case 1: Cat-girl and an unexpected renal biopsy A 10-year-old girl presents with a prolonged fever and rash, most prominent around the eyes, with annular lesions encircling the periorbital regions.

Background Immune thrombocytopenia (ITP) is a common hematologic manifestation in systemic lupus erythematosus (SLE). Thrombocytopenia can persist for more than one year, which is defined as chronic ...

Objective Patients with systemic lupus erythematosus (SLE) have an increased risk of cardiovascular disease (CVD), which is thought to be due to accelerated atherosclerosis. The aim of this study was ...

Objective Systemic lupus erythematosus is a prevalent autoimmune disease, with 20 to 40 percent of cases exhibiting thrombocytopenia. Conventional treatments involve corticosteroids and ...

Background Discoid lupus erythematosus (DLE) is one of the LE-specific skin diseases on the scalp, and some cases induce scarring alopecia. In systemic LE (SLE), variable nail changes not specific to ...

Purpose Rhupus is defined as an overlapping syndrome that combines the clinical and immunological features of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) simultaneously. The aim ...

This article was previously published with some errors. There was a discrepancy between the abstract and the full text regarding the number of patients on continuous hydroxychloroquine therapy over 5 ...

Background Little has been known regarding the biomarker to predict the treatment response in lupus nephritis. This study aimed to identify potential biomarkers that predict treatment response in ...

Background/ Purpose Hydroxychloroquine (HCQ) has demonstrated benefit in multiple outcomes in systemic lupus erythematosus (SLE), including disease activity, flare rates, survival, and thrombotic ...